Zavegepant was effective in relieving acute migraine symptoms, with a safety profile similar to other oral calcitonin gene-related peptide receptor antagonists.

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...

Ohio State Univ. developing nasal spray for loss of smell by COVID ...

The Food and Drug Administration (FDA) has issued a Complete Response Letter to Milestone Pharmaceuticals regarding the New Drug Application (NDA) for ...

A NASAL spray containing an anti-CD3 monoclonal antibody has shown promising results in ameliorating traumatic brain injury (TBI) in a mouse model, reducing central nervous system damage and improving ...